The early complement components C3 and C4, and the receptor C5aR have been reported as biomarkers for poor prognosis in gastric and colon cancers (2), with one mechanism being pro-tumor autocrine actions of C3a and C5a in the TME (3), including immune infiltration. This evidence concerns the gene C3 and colonic neoplasm.